Dr David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
I am a senior breast oncologist based in Leeds with a number of research and governance activities. I am the lead oncologist on the Sloane, NHS screening & national HQIP breast cancer audits.
I am a senior clinical research fellow to the EBCTCG and a member of steering groups for 12 ongoing UK trials in breast cancer. I sit on the trial management committees for 3 trials.
I am UK lead for the SACT project (UK chemotherapy database) and chair the clinical group, which provides input and advice to this project to examine the safety, efficacy and cost-effectiveness of chemotherapy used in England.
Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England
DODWELL D., (2020), Journal of Geriatric Oncology
Addressing frailty in patients with breast cancer: A review of the literature
Jauhari Y. et al, (2020), European Journal of Surgical Oncology, 46, 24 - 32
Immediate and delayed autologous abdominal microvascular flap breast reconstruction in patients receiving adjuvant, neoadjuvant or no radiotherapy: a meta‐analysis of clinical and quality‐of‐life outcomes
Khajuria A. et al, (2019), BJS Open
Eligibility for Partial Breast Radiotherapy in England.
Taylor CW. et al, (2019), Clin Oncol (R Coll Radiol)
Endocrine therapy in the years following a diagnosis of breast cancer: A proof of concept study using the primary care prescription database linked to cancer registration data.
Emanuel G. et al, (2019), Cancer Epidemiol, 61, 185 - 189